SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Accustem Sciences Inc. – ‘S-1’ on 11/17/22 – ‘EX-4.1’

On:  Thursday, 11/17/22, at 3:55pm ET   ·   Accession #:  1493152-22-32755   ·   File #:  333-268438

Previous ‘S-1’:  None   ·   Next & Latest:  ‘S-1/A’ on 1/19/23   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/17/22  Accustem Sciences Inc.            S-1                   66:33M                                    M2 Compliance LLC/FA

Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   2.16M 
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML    517K 
 3: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     17K 
10: EX-10.10    Material Contract                                   HTML    171K 
11: EX-10.11    Material Contract                                   HTML     17K 
 4: EX-10.4     Material Contract                                   HTML     25K 
 5: EX-10.5     Material Contract                                   HTML     35K 
 6: EX-10.6     Material Contract                                   HTML     34K 
 7: EX-10.7     Material Contract                                   HTML     34K 
 8: EX-10.8     Material Contract                                   HTML     23K 
 9: EX-10.9     Material Contract                                   HTML     24K 
12: EX-23.1     Consent of Expert or Counsel                        HTML     18K 
13: EX-FILING FEES  Calculation of Filing Fee Tables                HTML     25K 
19: R1          Cover                                               HTML     57K 
20: R2          Consolidated Balance Sheets                         HTML    106K 
21: R3          Consolidated Balance Sheets (Parenthetical)         HTML     36K 
22: R4          Consolidated Statements of Operations and           HTML     68K 
                Comprehensive Income (Loss)                                      
23: R5          Consolidated Statements of Shareholders' Equity     HTML     81K 
24: R6          Consolidated Statements of Cash Flows               HTML     97K 
25: R7          Nature of Business                                  HTML     51K 
26: R8          Summary of Significant Accounting Policies          HTML     76K 
27: R9          Acquisition of Stemprinter Sciences Limited and     HTML     34K 
                Equity Raise                                                     
28: R10         Note Payable                                        HTML     27K 
29: R11         Equipment                                           HTML     28K 
30: R12         License                                             HTML     40K 
31: R13         Loss Per Share                                      HTML     68K 
32: R14         Share-Based Compensation                            HTML    189K 
33: R15         Related Party Transactions                          HTML     34K 
34: R16         Income Taxes                                        HTML    103K 
35: R17         Commitments and Contingencies                       HTML     24K 
36: R18         Subsequent Events                                   HTML     27K 
37: R19         Summary of Significant Accounting Policies          HTML    118K 
                (Policies)                                                       
38: R20         Equipment (Tables)                                  HTML     24K 
39: R21         Loss Per Share (Tables)                             HTML     65K 
40: R22         Share-Based Compensation (Tables)                   HTML    162K 
41: R23         Income Taxes (Tables)                               HTML     92K 
42: R24         Nature of Business (Details Narrative)              HTML     71K 
43: R25         Summary of Significant Accounting Policies          HTML     25K 
                (Details Narrative)                                              
44: R26         Acquisition of Stemprinter Sciences Limited and     HTML     39K 
                Equity Raise (Details Narrative)                                 
45: R27         Note Payable (Details Narrative)                    HTML     33K 
46: R28         Schedule of Property and Equipment (Details)        HTML     26K 
47: R29         Equipment (Details Narrative)                       HTML     21K 
48: R30         License (Details Narrative)                         HTML     27K 
49: R31         Schedule of Loss Per Share (Details)                HTML     46K 
50: R32         Schedule of Computation of Diluted Net Loss Per     HTML     25K 
                Share (Details)                                                  
51: R33         Schedule of Stock Option Activity (Details)         HTML     75K 
52: R34         Schedule of Stock Based Compensation Expenses       HTML     26K 
                (Details)                                                        
53: R35         Schedule of Stock Valuation Assumptions (Details)   HTML     44K 
54: R36         Schedule of Warrants Outstanding (Details)          HTML     52K 
55: R37         Share-Based Compensation (Details Narrative)        HTML     82K 
56: R38         Related Party Transactions (Details Narrative)      HTML     48K 
57: R39         Schedule of Domestic and Foreign Components of      HTML     30K 
                Loss Before Income Taxes (Details)                               
58: R40         Schedule of Reconciliation Provision for Income     HTML     31K 
                Taxes (Details)                                                  
59: R41         Schedule of Deferred Income Tax Assets (Details)    HTML     27K 
60: R42         Income Taxes (Details Narrative)                    HTML     28K 
61: R43         Subsequent Events (Details Narrative)               HTML     41K 
64: XML         IDEA XML File -- Filing Summary                      XML    102K 
62: XML         XBRL Instance -- forms-1_htm                         XML   1.34M 
63: EXCEL       IDEA Workbook of Financial Reports                  XLSX    104K 
15: EX-101.CAL  Inline XBRL Taxonomy Extension Calculation           XML    109K 
                Linkbase Document -- acut-20220930_cal                           
16: EX-101.DEF  Inline XBRL Taxonomy Extension Definition Linkbase   XML    406K 
                Document -- acut-20220930_def                                    
17: EX-101.LAB  Inline XBRL Taxonomy Extension Label Linkbase        XML    720K 
                Document -- acut-20220930_lab                                    
18: EX-101.PRE  Inline XBRL Taxonomy Extension Presentation          XML    563K 
                Linkbase Document -- acut-20220930_pre                           
14: EX-101.SCH  Inline XBRL Taxonomy Extension Schema Document --    XSD     91K 
                acut-20220930                                                    
65: JSON        XBRL Instance as JSON Data -- MetaLinks              272±   394K 
66: ZIP         XBRL Zipped Folder -- 0001493152-22-032755-xbrl      Zip    780K 


‘EX-4.1’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 4.1

 

 

 C: 
 

 

 

 

 C: 
 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/22/24  Accustem Sciences Inc.            10-K       12/31/23   58:4.8M                                   M2 Compliance LLC/FA
 4/28/23  Accustem Sciences Inc.            10-K/A     12/31/22   12:482K                                   M2 Compliance LLC/FA
 2/15/23  Accustem Sciences Inc.            10-K       12/31/22   53:4.4M                                   M2 Compliance LLC/FA
 1/19/23  Accustem Sciences Inc.            S-1/A                 57:7M                                     M2 Compliance LLC/FA


2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/03/21  Accustem Sciences Inc.            8-K:1,2,3,512/01/21    7:813K                                   M2 Compliance LLC/FA
 3/12/21  Accustem Sciences Inc.            20FR12G                8:2.2M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001493152-22-032755   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 2:17:31.2am ET